-
Fierce Pharma Asia—Astellas CEO's BD plan; Takeda's US layoffs; Chugai's chase for name recognition
24 Jan 2026 00:56 GMT
… BD' as $6B Xtandi patent cliff nears
Despite Xtandi’s … upcoming patent cliff in 2027, Astellas CEO … hit with layoffs as key patent loss looms for Trintellix
Takeda … 2T won profit threshold
11. AstraZeneca pens $630M pact to secure …
-
Docetaxel Rechallenge May Edge Out Cabazitaxel in mCRPC
23 Jan 2026 11:17 GMT
… available, partly due to ongoing patent disputes that have delayed market … Astellas Pharma Inc, Bayer AG, AstraZeneca, Pfizer Inc, Johnson & Johnson …
-
Chemotherapy Drugs Market Grows at 9.0% CAGR Through 2033 | Persistence Market Research
23 Jan 2026 05:28 GMT
… ; Company
ImClone Systems Inc.
GlaxoSmithKline
AstraZeneca
Schering-Plough
Boehringer Ingelheim
Bristol …
Competitive Landscape and Recent Developments
Patent expirations are intensifying competition and …
-
Combination Inhalers Market to Grow at 6.3% CAGR Persistence Market Research
22 Jan 2026 07:50 GMT
… extensive clinical validation. Additionally, patent expirations of established ICS… Inhalers Market
Novartis AG
AstraZeneca plc
GlaxoSmithKline plc
Viatris … leading multinational players such as AstraZeneca, GlaxoSmithKline, Novartis, and Boehringer …
-
Is This Dividend King Stock a Buy After a Major Development?
22 Jan 2026 07:51 GMT
… administration. Others, namely Pfizer and AstraZeneca, have made similar moves.
Today … the loss of U.S. patent exclusivity for one of its … , which enable it to overcome patent cliffs, can help mitigate this …
-
Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic Experience
21 Jan 2026 22:55 GMT
… been on advisory boards for AstraZeneca, Bayer, Eisai, Exact Sciences … . BBT is a consultant for AstraZeneca, Boston Scientific, Genentech, Eisai, … Beau B Toskich has a patent 19/186,015 … Umair Majeed reports grants from AstraZeneca, during the conduct of …
-
COPD detected early with AI-powered electrocardiogram analysis
21 Jan 2026 15:43 GMT
… a consultant to Amgen, AstraZeneca, Chiesi, the COPD Foundation … American Lung Association, Areteia, AstraZeneca, the NIH and Sanofi … Sinai); receiving consulting fees from AstraZeneca, Chiesi, Genentech, GSK, … issued and three filed patents related to the …
-
How China Became the Biotech Industry’s Back-Office
21 Jan 2026 14:51 GMT
… operations of Boehringer Ingelheim, Pfizer, AstraZeneca, Roche, Eli Lilly, Novartis, GSK … ’s share of global biotech patents jumped from 1% in 2000 …
-
Pharma 2035 Playbook: Speed, focus and conviction in an uncertain world
20 Jan 2026 21:04 GMT
… are facing a looming patent cliff. Blockbuster drugs such … entirely around speed, and AstraZeneca warns that delays erase … Alzheimer’s, and AstraZeneca is redesigning oncology trials … of exclusivity, oncology innovation, patent cliff, pharma launch strategy, …
-
GSK: shareholders urge company to step up reinvention
20 Jan 2026 13:26 GMT
… recently seen at Pfizer, Sanofi, AstraZeneca and Novartis.
Emma Walmsley, who … to face a series of patent expiries in its HIV franchise …
About
© 1995-2026